跳至主要内容
临床试验/TCTR20191122002
TCTR20191122002终止4 期

The outcomes of combined endoscopic surgery and fibrinolytic treatment protocol for intraventricular hemorrhage: a randomized controlled trial

/A0 个研究点目标入组 110 人开始时间: 2019年11月22日最近更新:
适应症

试验速览

阶段
4 期
状态
终止
发起方
入组人数
110

研究概览

简要总结

This study demonstrated that combined ES and IVF is safe and effective for the treatment of IVH. In addition, it concluded that aggressive but safe procedures used to remove IVH could improve clinical outcome in patients with IVH.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • 1. age 18-80 years
  • 2. onset less than 24 hours prior to CT brain
  • 3. primary intraventricular hemorrhage or secondary from spontaneous intracerebral hemorrhage less than 20 ml
  • 4. obstructive hydrocephalus from blood clot in 3rd or 4th ventricles
  • 5. SBP < 200 mmHg or MAP <130 mmHg prior to treatment
  • 6. Modified Rankin Scale 0 or 1 before onset

排除标准

  • 1. Ruptured aneurysm, arteriovenous malformation (AVM), vascular anomaly, Moya-moya disease disease or tumor
  • 2. previous brain surgery less than 3 months
  • 3. uncorrectable bleeding disorders, platelet count less than 100,000, or INR more than 1.3
  • 4. pregnancy
  • 5. infratentorium hemorrhage
  • 6. severe unstable medical conditions such as uncontrolled cardiac disease
  • 7. subjects refuse to participate, unidentifiable subject, or unable to find consent for subject

研究者

发起方
/A

相似试验